Skip to main content
OpenTrials

Clinical trial condition

Herpesviridae Infections

Explore clinical trials studying Herpesviridae Infections. Study availability and eligibility vary by location and protocol.

1,823 public trials 252 recruiting studies
Refine in advanced search Browse all conditions

Herpesviridae Infections trial results

Completed

Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects

NCT03073967

Conditions
DNA Virus Infections, HSV Infection, Herpes Simplex, +7 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Metro Infectious Disease Consultants, LLC - Huntsville Huntsville, Alabama, United States
  • University of South Alabama Mobile, Alabama, United States
  • University Arizona - Department of Medicine Arizona Health Sciences Center Tucson, Arizona, United States
View all 70 locations
View Trial Details
Completed

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations

NCT02883049

Conditions
B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, Burkitt Lymphoma, +18 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • USA Health Strada Patient Care Center Mobile, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
View all 239 locations
View Trial Details
Completed

Trial to Evaluate the Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA)-Based Anti-Cytomegalovirus (CMV) Vaccine (Triplex®)

NCT05099965

Conditions
Blood-Borne Infections, Communicable Diseases, Cytomegalovirus Infections, +15 more
Locations
  • Alabama CRS Birmingham, Alabama, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • UCSD Antiviral Research Center San Diego, California, United States
  • Ucsf Hiv/Aids Crs San Francisco, California, United States
View Trial Details
Completed

ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies

NCT02362035

Conditions
Blood Protein Disorders, Burkitt Lymphoma, CLL, +47 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Los Angeles, California, United States
  • Research Site Denver, Colorado, United States
  • Research Site Washington D.C., District of Columbia, United States
View all 19 locations
View Trial Details

Related conditions